trans-4-Methoxycyclohexanamine hydrochloride

Catalog No. :
ACCWDU132
CAS No. :
61367-41-7
Molecular Formula :
C7H16ClNO
Molecular Weight :
165.66

IUPAC Name:(1r,4r)-4-methoxycyclohexan-1-amine hydrochloride

trans-4-Methoxycyclohexanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g98%$87.00Login to see priceIn stockIn stock
25g98%$216.00Login to see priceIn stockIn stock
100g98%$821.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametrans-4-Methoxycyclohexanamine hydrochloride
IUPAC Name(1r,4r)-4-methoxycyclohexan-1-amine hydrochloride
MDL No.MFCD18207785
Molecular FormulaC7H16ClNO
Molecular Weight165.66
SMILESN[C@H]1CC[C@H](OC)CC1.[H]Cl
InChI KeyDUVKXMNYICFZCS-MEZFUOHNSA-N
SynonymCyclohexanamine, 4-methoxy-, hydrochloride, trans- | AKOS024464154 | 4-methoxycyclohexylamine hydrochloride | SB37936 | 4-Methoxycyclohexanamine hydrochloride | J-640198 | MFCD18207785 | (1r,4r)-4-methoxycyclohexanamine hydrochloride | CS-0150204 | SY2051
CAS No.61367-41-7
PubChem CID21305025

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCWDU132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCWDU132 route product structure diagram
    ACCWDU13261367-41-7 In Stock
Inquiry

2. ACCWDU132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACCWDU132 route product structure diagram
    ACCWDU13261367-41-7 In Stock
Inquiry

Comments (0)